Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-016837
Filing Date
2009-03-30
Accepted
2009-03-30 12:26:49
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v144157_10k.htm 10-K 2138432
2 v144157_ex10-41.htm EX-10.41 268679
3 v144157_ex10-42.htm EX-10.42 82765
4 v144157_ex10-43.htm EX-10.43 101567
5 v144157_ex31-1.htm EX-31.1 11049
6 v144157_ex31-2.htm EX-31.2 10910
7 v144157_ex32-1.htm EX-32.1 6849
8 v144157_ex32-2.htm EX-32.2 6729
  Complete submission text file 0001144204-09-016837.txt   2628533
Mailing Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245
Business Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245 210 677 6000
ONCOVISTA INNOVATIVE THERAPIES, INC (Filer) CIK: 0001094847 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28347 | Film No.: 09712965
SIC: 2834 Pharmaceutical Preparations